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To the Editors, 
The European Respiratory Society (ERS) and American Thoracic Society (ATS) guideline on 
Management of COPD Exacerbations was published in the March 2017 issue of the European 
Respiratory  Journal (1). Based on evidence syntheses, including meta-analyses, relevant evidence 
until September 2015 was summarized, and clinical recommendations for treatment of COPD 
exacerbations were formulated. These Guidelines were endorsed by the ERS Executive 
Committee and approved by the ATS Board of Directors in December 2016.  
 
These guidelines should provide the basis for rational decisions in the treatment of COPD 
exacerbations. Unexpectedly, however, this ERS/ATS Task Force made a conditional 
recommendation against the initiation of pulmonary rehabilitation during hospitalisation; and a 
conditional recommendation in favour of starting pulmonary rehabilitation within three weeks 
after hospital discharge. Moreover, the Task Force rated the quality of evidence for both 
conditional recommendations to be very low. We take the liberty to challenge these conditional 
recommendations as well as the assessment of the evidence relating to them. Indeed, there are 
multiple arguments to recommend the initiation of pulmonary rehabilitation during and 
(especially) directly after hospitalisation.  
 
Patients with COPD report a broad spectrum of symptoms during exacerbations, including 
dyspnoea, depression, and fatigue (2), which seem to be the basis of the extreme declines in 
physical activity during hospitalizations (3). Additionally, comorbidities may flare up (4), and 
significant losses in quadriceps muscle strength (5), exercise tolerance (6) and health status occur 
during hospitalization (7), which only partially recover with usual care after discharge (3, 5, 8). 
Also, it has been shown that patients with anxiety and depression have a doubled risk of short-
term hospital re-admission (9). Therefore, we strongly believe that there is a clear rationale to 
start early rehabilitative interventions during the exacerbation-related hospitalization in patients 
with COPD, and to continue this after discharge. Importantly, the content of the integrated peri-
exacerbation pulmonary rehabilitation program (which is much more than physiotherapy alone) 
needs to be tailored to the patient’s physical and psychological status (10). 
 
Recent randomised controlled trials (RCTs) have shown that rehabilitative interventions initiated 
during patients’ hospital stay prevent a decline in lower-limb muscle function, balance and 
exercise performance, and facilitates recovery afterwards (11-15). These RCTs did not report 
serious adverse events. Starting early rehabilitation in the hospital setting is clearly also in line 
with international developments  to encourage early rehabilitative interventions, which are safe 
and effective for patients with a spectrum of illnesses, even in mechanically ventilated, critically ill 
patients (16-19).  
  
The current ERS/ATS Task Force concluded that pulmonary rehabilitation initiated during 
hospitalization increased mortality (1). This conclusion seems based solely on the study of 
Greening and colleagues, who reported a significant difference in mortality at 12 months between 
the rehabilitative group (starting with a median of 3 rehabilitative sessions during a median 5-day 
hospital stay, followed by a 6-week unsupervised home-based program, supported by telephone 
consultations) and the usual care control group (who did receive daily physiotherapy during 
hospitalization as per standard UK practice) (20). As argued previously (21), the difference in 
mortality began more than five months after the completion of the intervention. While of 
concern, the difference does not clearly relate to the early rehabilitation intervention. Indeed, the 
per protocol analysis did not show difference in mortality, suggesting that those who actually 
received the intervention were not the ones who came to harm (20). Moreover, post-hoc analyses 
showed that after statistical correction for an imbalance in the  degree of airflow limitation, the 
increased likelihood of dying in the early rehabilitation group compared to the usual care control 
group loses significance (GREENING et al. ERJ-01310-2017, UNDER REVIEW). Thus, it is questionable 
to base a conditional recommendation against the initiation of pulmonary rehabilitation during 
hospitalisation on a single trial and not on the entirety of evidence. Also, it is not entirely clear 
how the quality of the evidence relating to this recommendation was rated by the ERS/ATS task 
force (1), which  led to very different conclusions on the quality of the evidence compared to the 
recently updated Cochrane review (22). 
 
A conditional recommendation indicates that well-informed patients may make different choices 
regarding whether or not to have the intervention (1). While such preference-sensitive decision 
making is most welcome, it should be noted, that, unfortunately, patients with COPD are mostly 
unaware of the value of (peri-exacerbation) pulmonary rehabilitation programs for their health 
outcomes (23). Moreover, our anecdotal clinical experience shows that healthcare professionals 
who are uneducated in pulmonary rehabilitation are already using this ERS/ATS conditional 
recommendation to withhold  an early rehabilitative intervention in the peri-exacerbation period 
from patients. Indeed, during the ERS School Course on Pulmonary Rehabilitation (April 2017 in 
Athens, Greece), multiple concerns were expressed by participants that their local physicians read 
the ERS/ATS guideline on Management of COPD Exacerbations, and, in turn, did not refer for early 
pulmonary rehabilitation.  
 
On December 8 2016, Puhan and colleagues published an update of their Cochrane review 
entitled ‘Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary 
disease’, including twenty studies, and concluded that ‘Quality of life and exercise capacity were 
improved by rehabilitation, that the effect was substantially larger than the minimal important 
difference, and the quality of evidence according to GRADE was high. Results for hospital 
readmissions and mortality were diverse, with some studies showing that pulmonary rehabilitation 
reduced hospital admissions and mortality compared with usual community care (no rehabilitation), 
and other studies not showing such effects.’ (22). Based on the existing literature, we believe that 
the ERS/ATS Task Force should have made a strong recommendation in favour of starting 
pulmonary rehabilitation in the first weeks after hospital discharge, without the conditional 
reservation.  
 
To conclude, pulmonary rehabilitation ambassadors around the world have promoted pulmonary 
rehabilitation in patients with COPD during  and shortly after an exacerbation-related 
hospitalization (10, 24), as this results in clinically relevant improvements in exercise performance, 
lower-limb muscle function, balance and quality of life compared to usual care (22). Presently, 
more than 75% of current pulmonary rehabilitation programs include those patients (25). 
Obviously, we recognize the heterogeneity of effects on mortality and hospital re-admission, 
which should be monitored closely. As always, the specific content of the rehabilitation 
intervention in the peri-exacerbation period must be tailored carefully to the patient’s condition 
and needs.  Nevertheless, given the current evidence, the basis for the ERS/ATS conditional 
recommendation against the initiation of PR during hospitalization is not clear. This 
recommendation is therefore likely to have adverse impact on the quality of care, and in turn, the 
physical and emotional function and quality of life of these patients. We believe this 
recommendation is potentially harmful for the further broadening of the scope of pulmonary 
rehabilitation; and sets pulmonary rehabilitation 15 years back. Therefore, we would like to 
encourage healthcare professionals to educate their patients and recommend pulmonary 
rehabilitation in the peri-exacerbation period, as only 5 to 15% of hospitalized COPD patients are 
currently referred for early pulmonary rehabilitation (26). The ERS and ATS should commit to 
undertake actions that will improve access to and pulmonary rehabilitation services for suitable 
patients, including those with an exacerbation-related hospitalization (24).           
 
 
 * * * * * * 
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